Randi M, Ruzzon E, Luzzatto G, Tezza F, Girolami A, Fabris F. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. Haematologica [Internet]. 2005Feb.1 [cited 2026Nov.12];90(2):261-2. Available from: https://haematologica.org/article/view/3393